none
none

QUALITY NOT PRICE DRIVES AUSTRALIA’S HEALTHCARE MANUFACTURERS

28-11-2014
by 
in 

More than half (53%) of Life Sciences and Healthcare Manufacturers prioritise quality assurance over cost in selecting their supply chain partner, according to a new industry poll.

And the industry is on the fence (48% vs 52%) about whether the pharmaceutical industry will soon be comparable to the Fast Moving Consumer Goods (FMCG) market.

These are some of the key insights from DHL Supply Chain’s Healthcare Forum held in Sydney last week.

The annual event, which brought together 33 manufacturers from the sector, offers an opportunity for manufacturers, government and industry bodies to openly discuss the future of the industry and how supply chains can enable profitable growth.

A customer poll provided some interesting findings, including:

· 89% of customers believe Strategic Partnership to be the most important attribute when selecting a supply chain partner

· 72% of those polled said they expect the deregulation of industry bodies to have an impact on their bottom line, and

· 48% expressed their belief that the pharmaceuticals industry will be comparable to the FMCG market in the near future.

The event featured keynote addresses from Andrew Stuart, Deputy Secretary with the Department of Health, Laurie McAllister, Managing Director of Sanofi ANZ, and Saul Resnick, Managing Director at DHL Supply Chain Australia, who discussed how current industry trends affect supply chain operations and how best to adapt in an ever-changing landscape.

“Increased consumerism, generics and substitutions and highly specialised medications are all impacting what consumers expect and how the industry must evolve. These forums allow our customers to get in front of key industry figures and ask the questions that matter to them,” said Resnick.

“Providing life-saving products is a big responsibility, one with risks that far outweigh those in a typical supply chain environment. The robust discussion at this week’s forum highlighted the industry’s commitment to quality assurance, leveraging intelligence and creating innovative systems and processes as the market changes.”

Visiongain 2012 predicts a self-medication boom to support global revenue for over-the-counter medications of $81 billion by the end of 2014.

To learn more download DHL’s Key Logistics Trends in Life Sciences 2020+ whitepaper.

Related news & editorials

  1. 21.11.2017
    21.11.2017
    by      In
    Darcy Ewing of Kurrupt Kustoms in Albury NSW was running compressed air from a 6-year-old reciprocating piston-style compressor when (in his own words) it virtually “S*** itself!”.
    This left his high-end auto body and customisation shop in real trouble with a total shutdown of all essential... Read More
  2. 21.11.2017
    21.11.2017
    by      In
    If the recent upheavals in Australian manufacturing illustrate one truth, it is the absolute necessity for forward planning, and more to the point, the importance of planning for growth – regardless of a company’s existing size.
    While the ambition to grow a manufacturing operation is one thing,... Read More
  3. 21.11.2017
    21.11.2017
    by      In
    Blockchain technology was invented to make the world’s first crypto-currency, Bitcoin, possible. Traditional currencies rely on intermediaries like governments, banks and clearing houses to guarantee their value and process transactions. Bitcoin uses digital technologies to cut out these middlemen... Read More
  4. 21.11.2017
    21.11.2017
    by      In
    Australian Tank Engineering (ATE Tankers) has been engineering and manufacturing tankers in Australia for nearly two decades. But whereas most vehicle manufacturers have seen sales decline in recent years, ATE has elevated itself through the trend with a transformative mindset that has enabled the... Read More